{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"autosomal-recessive-hyperinsulinism-due-to-kir6-2-deficiency","columns":[{"gene":"","key":"population-7d5a0090b9e7ad844042","label":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","mondoId":"MONDO:0019334","onsetQualifier":null,"originColumnKey":"MONDO:0019334/ORPHA:79644","originalViews":[{"key":"MONDO:0019334/ORPHA:79644","label":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","scopeLabel":"ORPHA:79644","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["158ece8612b40edd789c38e161cbf792e896e4055be79465431bd0458ac9adce","261498c04277cde197f7fa2f9e8eab10174b5bec166a853b7cd28d47ee1843dc","2617a153691c6b97df1a435bd9290e59c29d33950eb413bb27b713a08ec634ec","32cffbf087206a0a1ce458414d1fe0b720ea3e114125f411dce039d4804bd387","3808ae606b4b92bcf9e1f1b864733cb2da2e9b64f40dba3bdc916f1e6f987726","3f550eba4fab91f17e62673926d65425418ec1b9ff01069a9419eca8c2eec975","56ccb5c441c40b7c0e71df1ff53bdd878c549997732533842ff27ecfd2afb5a4","5884236821c844a06d98e31a59ab852e7c60b0cfe6799051df941e6c8f6d3266","5e32f307fb33e08719b253c6498986f242b757cd223121bd9fd34e3f57687e83","65cae70fac6c588da1c1b262ac5584827d1cb656907d0b0ef7fedc9a16a3947b","6aacd8eeda235769d9fef68333510748bc9d3971fe5cb8e8c89daf65097bf060","7b0fefa424987287fb0fab539fb360ed1ca2ebb20fd3c6ce545ed2e32f82801b","7d6cbc0fbfa9dbce77e993c7141092fcb5e6448a3c63461831b376294037b0b6","8439fdc82f3163de57b6db3f3b6d0ddc885152fb655bb55d20f1eafec1dd29b0","9c7e4e346734e67994547a44a4f77f45c3d5211731c76fc8d1c3fc0b65af61e2","aae9b256eac3706c6596af070d7c0626abed2edbc9d21fd3ac218fa4ba2c57d0","b3b9e7c3bbb0e45a442aa83ec3652d9964e636f9514314e567a1d88d788412d5","c4e0a5fe9fa4897f11c9476946d0895d224fc58d97e85f7da164ce7d3f01941a","c7f8667a52bdab6c8c242369b652db207b9aac6cd33d931f4df665c9b3cc1180","e2e5e406cd94d21b8c453f45d8991d4aa2786cf5d78199a7b45412fc7cd4ba93"],"recordQualifiers":{},"scopeLabel":"ORPHA:79644","sourceIds":["ORPHA:79644"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-7d5a0090b9e7ad844042"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0031080","HP:0000707","HP:0002104","HP:0040299","HP:0031224","HP:0030796","HP:0000845"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":20,"sourceGroups":{"orphanet":20}},"features":[{"hpoId":"HP:0031080","label":"Abnormal response to glucagon stimulation test","primary":true},{"hpoId":"HP:0000707","label":"Abnormality of the nervous system","primary":true},{"hpoId":"HP:0002104","label":"Apnea","primary":true},{"hpoId":"HP:0040299","label":"Decreased circulating free fatty acid level","primary":true},{"hpoId":"HP:0031224","label":"Diffuse pancreatic islet hyperplasia","primary":true},{"hpoId":"HP:0030796","label":"Elevated circulating C-peptide concentration","primary":true},{"hpoId":"HP:0000845","label":"Elevated circulating growth hormone concentration","primary":true},{"hpoId":"HP:0011968","label":"Feeding difficulties","primary":false},{"hpoId":"HP:0008947","label":"Floppy infant","primary":false},{"hpoId":"HP:0031223","label":"Focal pancreatic islet hyperplasia","primary":false},{"hpoId":"HP:0000825","label":"Hyperinsulinemic hypoglycemia","primary":false},{"hpoId":"HP:0003118","label":"Increased circulating cortisol level","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0002919","label":"Ketonuria","primary":false},{"hpoId":"HP:0001520","label":"Large for gestational age","primary":false},{"hpoId":"HP:0008194","label":"Multiple pancreatic beta-cell adenomas","primary":false},{"hpoId":"HP:0001998","label":"Neonatal hypoglycemia","primary":false},{"hpoId":"HP:0012758","label":"Neurodevelopmental delay","primary":false},{"hpoId":"HP:0001988","label":"Recurrent hypoglycemia","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false}],"ledeHtml":"A rare, congenital, isolated hyperinsulinism disorder characterized by neonatal presentation of severe refractory hypoglycemia in the first two days of life, with limited response to medical management, sometimes requiring pancreatic resection. Newborns are often large for gestational age with mild to moderate hepatomegaly and diffuse form of hyperinsulinism due to Kir6.2 deficiency. Persistent hypoglycemia, hyperglycemia and type1 diabetes mellitus may develop later in life. Life-threatening hypoglycemic coma or status epilepticus have also been associated.","mondoId":"MONDO:0019334","node":{"canonicalSlug":"autosomal-recessive-hyperinsulinism-due-to-kir6-2-deficiency","comparisons":[{"documentSha256":"694c1a6d64dc5380af3aeb2b7a6f4cd02838442544e7be9faa4339e1e2b1ece2","key":"legacy-hyperinsulinemic-hypoglycemia","kind":"legacy","label":"hyperinsulinemic hypoglycemia","memberIds":["MONDO:0005803","MONDO:0009734","MONDO:0011153","MONDO:0011236","MONDO:0011717","MONDO:0012381","MONDO:0012382","MONDO:0012396","MONDO:0016988","MONDO:0017183","MONDO:0017184","MONDO:0017185","MONDO:0017189","MONDO:0017935","MONDO:0018465","MONDO:0019334","MONDO:0859362"],"mondoId":"MONDO:0005803","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hyperinsulinemic-hypoglycemia.694c1a6d64dc5380af3aeb2b7a6f4cd02838442544e7be9faa4339e1e2b1ece2.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","originalSourceId":"ORPHA:79644","paragraphs":["A rare, congenital, isolated hyperinsulinism disorder characterized by neonatal presentation of severe refractory hypoglycemia in the first two days of life, with limited response to medical management, sometimes requiring pancreatic resection. Newborns are often large for gestational age with mild to moderate hepatomegaly and diffuse form of hyperinsulinism due to Kir6.2 deficiency. Persistent hypoglycemia, hyperglycemia and type1 diabetes mellitus may develop later in life. Life-threatening hypoglycemic coma or status epilepticus have also been associated."],"rawAttribution":"ORPHA:79644","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:42:04Z","upstream":"ORPHA:79644","url":"https://rarediseases.info.nih.gov/diseases/16727"},"ownColumnKeys":["population-7d5a0090b9e7ad844042"],"publication":"published","relationships":[{"kind":"parent","label":"hyperinsulinemic hypoglycemia, familial, 2","mondoId":"MONDO:0011153","slug":"hyperinsulinemic-hypoglycemia-familial-2"},{"kind":"parent","label":"diazoxide-resistant diffuse hyperinsulinism","mondoId":"MONDO:0015625","slug":"diazoxide-resistant-diffuse-hyperinsulinism"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[{"frequencyKind":"range","key":"158ece8612b40edd789c38e161cbf792e896e4055be79465431bd0458ac9adce","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031223","is_excluded":false,"label":"Focal pancreatic islet hyperplasia","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"261498c04277cde197f7fa2f9e8eab10174b5bec166a853b7cd28d47ee1843dc","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011968","is_excluded":false,"label":"Feeding difficulties","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2617a153691c6b97df1a435bd9290e59c29d33950eb413bb27b713a08ec634ec","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012758","is_excluded":false,"label":"Neurodevelopmental delay","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"32cffbf087206a0a1ce458414d1fe0b720ea3e114125f411dce039d4804bd387","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0031080","is_excluded":false,"label":"Abnormal response to glucagon stimulation test","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3808ae606b4b92bcf9e1f1b864733cb2da2e9b64f40dba3bdc916f1e6f987726","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000845","is_excluded":false,"label":"Elevated circulating growth hormone concentration","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3f550eba4fab91f17e62673926d65425418ec1b9ff01069a9419eca8c2eec975","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002104","is_excluded":false,"label":"Apnea","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"56ccb5c441c40b7c0e71df1ff53bdd878c549997732533842ff27ecfd2afb5a4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001988","is_excluded":false,"label":"Recurrent hypoglycemia","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5884236821c844a06d98e31a59ab852e7c60b0cfe6799051df941e6c8f6d3266","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003118","is_excluded":false,"label":"Increased circulating cortisol level","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"5e32f307fb33e08719b253c6498986f242b757cd223121bd9fd34e3f57687e83","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002919","is_excluded":true,"label":"Ketonuria","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"65cae70fac6c588da1c1b262ac5584827d1cb656907d0b0ef7fedc9a16a3947b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001998","is_excluded":false,"label":"Neonatal hypoglycemia","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6aacd8eeda235769d9fef68333510748bc9d3971fe5cb8e8c89daf65097bf060","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0030796","is_excluded":false,"label":"Elevated circulating C-peptide concentration","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7b0fefa424987287fb0fab539fb360ed1ca2ebb20fd3c6ce545ed2e32f82801b","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0000825","is_excluded":false,"label":"Hyperinsulinemic hypoglycemia","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7d6cbc0fbfa9dbce77e993c7141092fcb5e6448a3c63461831b376294037b0b6","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001520","is_excluded":false,"label":"Large for gestational age","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8439fdc82f3163de57b6db3f3b6d0ddc885152fb655bb55d20f1eafec1dd29b0","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9c7e4e346734e67994547a44a4f77f45c3d5211731c76fc8d1c3fc0b65af61e2","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031224","is_excluded":false,"label":"Diffuse pancreatic islet hyperplasia","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"aae9b256eac3706c6596af070d7c0626abed2edbc9d21fd3ac218fa4ba2c57d0","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0008947","is_excluded":false,"label":"Floppy infant","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b3b9e7c3bbb0e45a442aa83ec3652d9964e636f9514314e567a1d88d788412d5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000707","is_excluded":false,"label":"Abnormality of the nervous system","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c4e0a5fe9fa4897f11c9476946d0895d224fc58d97e85f7da164ce7d3f01941a","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0008194","is_excluded":false,"label":"Multiple pancreatic beta-cell adenomas","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c7f8667a52bdab6c8c242369b652db207b9aac6cd33d931f4df665c9b3cc1180","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0040299","is_excluded":false,"label":"Decreased circulating free fatty acid level","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e2e5e406cd94d21b8c453f45d8991d4aa2786cf5d78199a7b45412fc7cd4ba93","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79644","disease_name":"Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:79644","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/16727\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:79644</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare, congenital, isolated hyperinsulinism disorder characterized by neonatal presentation of severe refractory hypoglycemia in the first two days of life, with limited response to medical management, sometimes requiring pancreatic resection. Newborns are often large for gestational age with mild to moderate hepatomegaly and diffuse form of hyperinsulinism due to Kir6.2 deficiency. Persistent hypoglycemia, hyperglycemia and type1 diabetes mellitus may develop later in life. Life-threatening hypoglycemic coma or status epilepticus have also been associated.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/16727\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"autosomal-recessive-hyperinsulinism-due-to-kir6-2-deficiency","sourceDocuments":[{"name":"GARD: Autosomal recessive hyperinsulinism due to Kir6.2 deficiency","reviewed":null,"source_release":"2026-10-25T03:42:04Z","url":"https://rarediseases.info.nih.gov/diseases/16727"}],"sourceNote":"","synonyms":["autosomal recessive hyperinsulinemic hypoglycemia due to Kir6.2 deficiency"],"takeawayHtml":"","title":"autosomal recessive hyperinsulinism due to Kir6.2 deficiency"},"schemaVersion":1}
